SEOUL, May 26 (UPI) – The South Korean Ministry of Food and Pharmaceutical Safety has officially approved a cardiac monitoring feature for Samsung’s health app, allowing smartwatch users to keep an eye on their blood pressure.
Seoul-based tech giant said on Sunday that the Samsung Galaxy Watch Active2 will allow its users to measure and analyze their heart rates starting in the third quarter of this year.
Users will also be able to check for any heart irregularities under the authority of the Ministry of Food and Drug Safety.
Samsung explains how it works:
“Just open the Samsung Health Monitor app when you’re comfortably seated and make sure the watch is securely attached to your wrist. Then put your forearm on a flat surface and lightly place the fingertip of the opposite hand on the upper button of the Galaxy Watch Active2 for 30 seconds. The application will then measure your heart rate and your rhythm. “
Users of Galaxy watches in other countries will have to wait a little longer to take advantage of the ECG and blood pressure monitoring technology. Samsung has yet to obtain approval from local authorities in different regions.
In the United States, this technology is expected to be approved by the United States Food and Drug Administration.
In recent years, global manufacturers of smartphones and smart devices have attempted to integrate medical services into their products, including Apple.
The company’s new Apple Watch Series 4 was approved in 2018 as an FDA Class 2 medical device, which offers on-demand measurements for three different health measures and detects falls.
The Apple Watch is designed to track the ECG and to alert users when they have a low heart rate or irregular heart rhythms.